Moderate

Uterine fibroids (leiomyoma/myoma)

Benign oestrogen-dependent smooth-muscle tumours of the uterus; common cause of heavy menstrual bleeding, pressure symptoms and subfertility. Includes acute red (carneous) degeneration in pregnancy. DRAFT for clinician review. · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Fibroids (leiomyomas) are benign monoclonal smooth-muscle tumours of the myometrium, very common (especially in women of African ancestry) and oestrogen/progesterone-dependent. Many are asymptomatic; symptomatic ones cause heavy and/or prolonged menstrual bleeding (submucosal/intramural), pressure effects (urinary frequency, constipation, bloating), pelvic pain/dysmenorrhoea, and subfertility or recurrent miscarriage. Examination may reveal an enlarged, firm, irregular, non-tender uterus. In pregnancy they may undergo painful red (carneous) degeneration. Rare acute presentations: torsion of a pedunculated fibroid, or prolapsing submucosal fibroid. Malignant change (leiomyosarcoma) is very rare. Management ranges from observation to medical therapy, uterine artery embolisation and surgery, guided by symptoms and fertility wishes.

Red flags

  • Severe acute pelvic pain (torsion of pedunculated fibroid, red degeneration, prolapsing/infarcted submucosal fibroid)
  • Haemodynamic compromise from heavy menstrual bleeding (acute anaemia)
  • Rapidly enlarging fibroid or growth after menopause (consider leiomyosarcoma — rare)
  • Postmenopausal bleeding (exclude endometrial cancer)
  • Hydronephrosis / renal impairment from a large compressing fibroid
  • Urinary retention or bowel obstruction from pressure

Assessment

Differential diagnosis

  • Adenomyosis
  • Endometrial/endometrial polyp or hyperplasia/cancer (esp. if postmenopausal bleeding)
  • Ovarian mass
  • Pregnancy (gravid uterus) / fibroid in pregnancy
  • Other causes of heavy menstrual bleeding (coagulopathy, thyroid, anovulation)
  • Leiomyosarcoma (rare; rapid growth, postmenopausal growth)
  • Endometriosis

Investigations

  • Pelvic examination (enlarged irregular firm uterus)
  • Transvaginal/transabdominal ultrasound (first-line imaging: number, size, location of fibroids)
  • FBC (iron-deficiency anaemia from menorrhagia); ferritin
  • MRI pelvis if mapping before surgery/embolisation or diagnostic uncertainty
  • Hysteroscopy +/- endometrial biopsy for submucosal fibroids or to exclude endometrial pathology (esp. if risk factors / abnormal bleeding)
  • Pregnancy test (fibroid vs gravid uterus; red degeneration)
  • Assess for pressure effects (renal tract if large — hydronephrosis)

Management

  • Confirm diagnosis and characterise fibroids on ultrasound; correct anaemia (iron +/- transfusion if severe)
  • Asymptomatic fibroids: usually observe; no treatment needed
  • For heavy menstrual bleeding: medical options first — tranexamic acid and/or NSAIDs for bleeding, hormonal options (levonorgestrel intrauterine system if cavity suitable, combined hormonal contraception, progestogens)
  • For symptom/size control pre-surgery or short-term: GnRH analogues (shrink fibroids, improve anaemia) with add-back HRT; or selected newer agents
  • Uterine-sparing procedures: uterine artery embolisation, myomectomy (hysteroscopic for submucosal; laparoscopic/open for larger) — preferred if fertility desired
  • Hysterectomy for definitive treatment when family complete and symptoms severe
  • In pregnancy with red degeneration: conservative management — analgesia, rest, hydration (self-limiting); avoid surgery
  • Acute: torsion of pedunculated fibroid or prolapsing/infected submucosal fibroid may need surgery
  • Manage subfertility jointly with fertility services (myomectomy for cavity-distorting fibroids)

Drugs & doses

Tranexamic acid 1 g PO three times daily during menstruation (reduces heavy bleeding; non-hormonal) [verify local]
Mefenamic acid 500 mg PO three times daily or ibuprofen/naproxen during menses (reduce bleeding + pain)
Levonorgestrel intrauterine system (if uterine cavity not distorted) — reduces menstrual loss long-term
Combined hormonal contraception or oral progestogen (e.g. norethisterone) for bleeding control [verify local]
GnRH agonist e.g. goserelin 3.6 mg SC monthly (shrinks fibroids/improves anaemia pre-op) with add-back HRT; short-term use [verify local]
Iron: ferrous sulfate 200 mg PO (or ferrous fumarate) once-twice daily for iron-deficiency anaemia; IV iron or transfusion if severe/symptomatic
Analgesia (paracetamol +/- NSAID +/- short opioid) for red degeneration in pregnancy; manage conservatively
Ulipristal acetate is now restricted (hepatotoxicity) — use only under specialist criteria where still licensed [verify local]

Disposition

Outpatient gynaecology for symptomatic fibroids; correct anaemia. Admit for acute severe pain (torsion/degeneration), heavy bleeding with haemodynamic compromise, or urinary retention. Interventional radiology for embolisation; surgery (myomectomy/hysterectomy) as planned. Fertility services if subfertile. Urgent referral for suspected malignancy (rapid growth/postmenopausal bleeding).

Complications & pitfalls

  • Iron-deficiency anaemia from menorrhagia
  • Pressure effects: urinary frequency/retention, hydronephrosis, constipation
  • Subfertility, recurrent miscarriage, obstetric complications (malpresentation, obstructed labour, PPH, red degeneration)
  • Torsion of pedunculated fibroid; prolapse/infection of submucosal fibroid
  • Rare malignant transformation (leiomyosarcoma)
  • Treatment complications (embolisation syndrome, surgical/anaesthetic risks)

Exam pearls

  • Enlarged, firm, irregular, non-tender uterus with heavy periods = think fibroids; confirm on ultrasound.
  • Tranexamic acid and the levonorgestrel IUS are effective non-surgical options for fibroid-related heavy bleeding (IUS needs an undistorted cavity).
  • GnRH analogues shrink fibroids and correct anaemia before surgery but are only short-term (bone loss) — use add-back HRT.
  • Choose uterine-sparing options (myomectomy, embolisation) if fertility is desired; hysterectomy is definitive.
  • Red (carneous) degeneration in pregnancy is painful but self-limiting — treat conservatively, not surgically.
  • Rapid growth or postmenopausal enlargement is a red flag for rare leiomyosarcoma.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.